Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Reksa Dana Premier ETF Indonesia Consumer (XIIC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan UBC Medical Indonesia Tbk. dan Reksa Dana Premier ETF Indonesia Consumer: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Reksa Dana Premier ETF Indonesia Consumer diperdagangkan di Rp735 (kapitalisasi pasar 1,61 M, volume 24 jam 29,7 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 358,2× kapitalisasi pasar Reksa Dana Premier ETF Indonesia Consumer, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 29,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | XIIC | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 1,61 M |
Volume | 3,48 jt | 29,7 rb |
Lot | 34,82 rb | 297 |
Perputaran | 522,79 jt | 22,22 jt |
Harga Rata-rata | 150,13 | 748,06 |
Nilai Transaksi | 522,79 jt | 22,22 jt |
Harga Ekuilibrium Indikatif | 148 | — |
Volume Ekuilibrium Indikatif | 350 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
